Natasha B Leighl, BSc, MMSc, MD

Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Keywords: thoracic oncology, lung cancer, clinical trials, liquid biopsy, drug development, outcomes research
  • Novel therapeutics in thoracic cancers including early phase trials
  • Targeted therapy trials, genomics in thoracic cancers
  • Immunotherapy trials in thoracic cancers 
  • Novel diagnostics including practical applications of liquid biopsy
  • Outcomes research 

 

Related Links

Associated Program(s)

For a list of Dr. Leighl's publications, please visit PubMed or Scopus.

Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

Professor, Department of Medicine, University of Toronto
Professor (status), Institute of Health Policy, Management and Evaluation, University of Toronto
Past President and Honorary Lifetime Member, Lung Cancer Canada
Past Chair, Committee on Economic Analysis, Canadian Clinical Trials Group